Production of VLDL-TG is in part due to be the increased flux of FFA to the liver in combination with insulin resistance associated hyperinsulinemia [57,58] and this may be a way linking the role of IL-18 in skeletal muscle to dyslipidemia. The gene discussed is IL18; the disease is hyperinsulinism.